GlassScriptPhysician profile
Kevin M James
NPI 1013176023
$4,391.23
in general payments reported to CMS, 2019-2025
41 companies · $759 in 2025
The $759 reported for 2025 was more than what 86% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $402 · 2021: $348 · 2022: $502 · 2023: $892 · 2024: $997 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,648.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $470.07 | 2019-2024 | |
| Novo Nordisk INC | $459.42 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $427.72 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $274.22 | 2019-2025 | Ingrezza |
| Glaxosmithkline, LLC. | $266.19 | 2019-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $215.56 | 2023-2025 | Kisunla, Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $178.66 | 2023-2025 | Rexulti |
| Eisai INC. | $174.19 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $171.52 | 2019-2025 | Eliquis, Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $151.40 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $148.74 | 2023-2025 | Farxiga |
| Sumitomo Pharma America, INC. | $114.53 | 2023-2025 | Gemtesa |
| Corium, LLC | $111.58 | 2022-2023 | Adlarity |
| Merck Sharp & Dohme LLC | $95.11 | 2019-2024 | Dificid |
| La Jolla Pharmaceutical Company | $88.71 | 2023-2024 | Xerava, Giapreza |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.